Description
MD-HIP
Description
Medical device useful for improving the mobility of the hip joint, whose primary therapeutic treatment consists of the following functions:
1. Barrier effect.
2. Lubricating activity.
3. Mechanical support in case of ongoing drug therapy.
The use of MD-HIP by qualified healthcare personnel in private or public healthcare facilities is recommended for:
- improve hip joint mobility;
- promote muscle relaxation in the lumbar-sacral area;
- support the periarticular muscle structures;
- relieve localized pain, or pain caused by joint movement or postural defects.
How to use
MD-HIP can be used alone or in combination with other medical devices from the same line, in order to guarantee personalized treatment based on the individual clinical picture.
In cases where supportive treatment is required for the onset of acute pain, MD-HIP can be combined with MD-NEURAL, MD-POLY and MD-MUSCLE (one or more of these).
Furthermore, in cases where tissue matrix support therapy is required or a slowing down of physiological aging is necessary, MD-HIP can be combined with MD-MATRIX and MD-TISSUE.
Therapeutic protocol
1 treatment per week for 10 consecutive weeks.
Method of administration: periarticular injection (the application area must be aseptic; insert the needle to a depth of 6-8 mm).
For this use of the medical device, the use of the following materials and accessories is recommended:
• Material to ensure skin asepsis: disposable glove, iodine-based solution, alcohol solution, sterile gauze, ethyl chloride-based skin spray.
• Needles: sterile 27 G.
• Syringes: 5 or 10 cc, depending on the quantity of solution to be injected.
Method of administration: intra-articular injection.
For this use of the medical device, the use of the following materials and accessories is recommended:
• Material to ensure skin asepsis: disposable glove, iodine-based solution, alcohol solution, sterile gauze, ethyl chloride-based skin spray. The application of a local anesthetic on the treated skin is recommended.
• Needles: sterile 22 G.
• Syringes: 2 cc, depending on the quantity of solution to be injected.
Components
Collagen of porcine origin.
Excipients: calcium phosphate, NaCl, water for injection.
Warnings
Disposable.
Patients on anticoagulant therapy or with known capillary fragility should be kept under close observation during therapy.
No case of hypersensitivity to MD-HIP has been reported.
Contains collagen of animal origin from porcine species. Patients with known hypersensitivity to the component or excipients must first undergo an injection test in the arm and be kept under observation for one hour.
Coxalgia requires differential diagnosis with pain secondary to primary or metastatic tumors, reflex neuralgia of lumbar origin, inguinal hernia.
Slight redness at the injection area may be due to the mechanical effect of the needle or a skin reaction.
The application may cause burning/pain symptoms at the injection sites, which generally resolve within 5-10 minutes after the end of treatment.
Skin cleaning/disinfection is required before and after application.
Any pyogenic bacteria may produce an abscess in the injection area.
Keep out of the reach and sight of children.
Do not use after expiration.
Use the product immediately after opening.
Do not use if seal is broken or tampered with.
After opening, the contents of the vial must be injected immediately.
Do not use if packaging is damaged.
Conservation
Store at a temperature between 2°C and 30°C, protect from sunlight and frost.
The expiry date refers to the product in its intact packaging, stored correctly.
Format
Pack of 10 sterile 2 ml vials
Cod. MD01
Medical device useful for improving the mobility of the hip joint, whose primary therapeutic treatment consists of the following functions:
1. Barrier effect.
2. Lubricating activity.
3. Mechanical support in case of ongoing drug therapy.
The use of MD-HIP by qualified healthcare personnel in private or public healthcare facilities is recommended for:
- improve hip joint mobility;
- promote muscle relaxation in the lumbar-sacral area;
- support the periarticular muscle structures;
- relieve localized pain, or pain caused by joint movement or postural defects.
How to use
MD-HIP can be used alone or in combination with other medical devices from the same line, in order to guarantee personalized treatment based on the individual clinical picture.
In cases where supportive treatment is required for the onset of acute pain, MD-HIP can be combined with MD-NEURAL, MD-POLY and MD-MUSCLE (one or more of these).
Furthermore, in cases where tissue matrix support therapy is required or a slowing down of physiological aging is necessary, MD-HIP can be combined with MD-MATRIX and MD-TISSUE.
Therapeutic protocol
1 treatment per week for 10 consecutive weeks.
Method of administration: periarticular injection (the application area must be aseptic; insert the needle to a depth of 6-8 mm).
For this use of the medical device, the use of the following materials and accessories is recommended:
• Material to ensure skin asepsis: disposable glove, iodine-based solution, alcohol solution, sterile gauze, ethyl chloride-based skin spray.
• Needles: sterile 27 G.
• Syringes: 5 or 10 cc, depending on the quantity of solution to be injected.
Method of administration: intra-articular injection.
For this use of the medical device, the use of the following materials and accessories is recommended:
• Material to ensure skin asepsis: disposable glove, iodine-based solution, alcohol solution, sterile gauze, ethyl chloride-based skin spray. The application of a local anesthetic on the treated skin is recommended.
• Needles: sterile 22 G.
• Syringes: 2 cc, depending on the quantity of solution to be injected.
Components
Collagen of porcine origin.
Excipients: calcium phosphate, NaCl, water for injection.
Warnings
Disposable.
Patients on anticoagulant therapy or with known capillary fragility should be kept under close observation during therapy.
No case of hypersensitivity to MD-HIP has been reported.
Contains collagen of animal origin from porcine species. Patients with known hypersensitivity to the component or excipients must first undergo an injection test in the arm and be kept under observation for one hour.
Coxalgia requires differential diagnosis with pain secondary to primary or metastatic tumors, reflex neuralgia of lumbar origin, inguinal hernia.
Slight redness at the injection area may be due to the mechanical effect of the needle or a skin reaction.
The application may cause burning/pain symptoms at the injection sites, which generally resolve within 5-10 minutes after the end of treatment.
Skin cleaning/disinfection is required before and after application.
Any pyogenic bacteria may produce an abscess in the injection area.
Keep out of the reach and sight of children.
Do not use after expiration.
Use the product immediately after opening.
Do not use if seal is broken or tampered with.
After opening, the contents of the vial must be injected immediately.
Do not use if packaging is damaged.
Conservation
Store at a temperature between 2°C and 30°C, protect from sunlight and frost.
The expiry date refers to the product in its intact packaging, stored correctly.
Format
Pack of 10 sterile 2 ml vials
Cod. MD01
